BackVerve Therapeutics Overview

Verve Therapeutics Receivables

Verve Therapeutics's receivables is $0.

Get informed when a big investor buys or sells

+ Follow
Receivables
$0.00
100.00% YoYΔ $-5.77M vs prior year quarter

Peer average

Loading

Verve Therapeutics Receivables History

Loading

Verve Therapeutics vs. peers: Receivables Comparison

Loading

Verve Therapeutics Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Verve Therapeutics (VERV) FAQ

As of the most recent data (March 2025), VERV shows a receivables of $0. That compares with $5.8M in the prior-year period — down 100.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, VERV's receivables is now $0 (was $5.8M) — a 100.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Verve Therapeutics is outperforming or lagging.

Tracking VERV's receivables over time shows whether Verve Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $0 That compares with $5.8M in the prior-year period — down 100.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Verve Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $0) with ownership activity and broader fundamentals.

Verve Therapeutics's receivables is $0; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.